Now showing items 1-3 of 3
Long-term Survival in Patients with Severe Acute Respiratory Distress Syndrome and Rescue Therapies for Refractory Hypoxemia
<italic>Objective</italic>: To assess survival up to 5 years in patients who develop severe acute respiratory distress syndrome (ARDS) and evaluate differences in characteristics and outcomes for patients selected for treatment with a rescue therapy (inhaled nitric oxide, inhaled epoprostenol or prone position ventilation) ...
Implications and Investigations of Pharmacy Benefit in the United States
Medicaid clients are among the most at-risk members for poor health outcomes in society and this safety net health care is critical for assuring continuous access to medical care. We will describe the importance of curtailing unnecessary drug spend as well as generic utilization mechanisms already applied by payers. We will ...
Comparative Effectiveness Approaches to Evaluate Pharmacogenomic Technology
Background Recent advances in genomic science present opportunities to "personalize" pharmaceutical treatments and improve health outcomes. However, such improvements are impeded by sparse evidence assessing pharmacogenomic technology clinical utility. This uncertainty constrains stakeholder decision-making, and has resulted ...